300030 Improve Medical Instruments
- 4.73
- +0.08+1.72%
Improve Medical Instruments News
Yangpu Medical (300030.SZ): Yangpu Devices obtained environmental management system certification
Gelonghui, April 30 | Yangpu Medical (300030.SZ) announced that Guangzhou Yangpu Medical Devices Co., Ltd. (“Yangpu Equipment”), a wholly-owned subsidiary of the company, recently obtained the “Environmental Management System Certification” issued by Fangyuan Logo Certification Group Co., Ltd.
Yangpu Healthcare (300030.SZ) announced first-quarter results, turning profit into loss to $3.19,900
Yangpu Medical (300030.SZ) released its report for the first quarter of 2024. The company's revenue was 1.41...
Yangpu Medical (300030.SZ): Chairman and General Manager Deng Guanhua was investigated and placed in custody
Zhitong Finance App News, Yangpu Healthcare (300030.SZ) announced that the company recently received the “Notice of Case Filing” and “Notice of Detention” issued by the Guangdong Provincial Supervisory Commission. Deng Guanhua, the chairman and general manager of the company, was investigated and placed in lien for suspected disciplinary violations.
Yangpu Medical (300030.SZ): Chairman and General Manager Deng Guanhua was placed in lien
Gelonghui, April 7 | Yangpu Medical (300030.SZ) announced that it recently received the “Notice of Case Filing” and “Notice of Detention” issued by the Guangdong Provincial Supervisory Commission. Mr. Deng Guanhua, the chairman and general manager of the company, was investigated and placed in detention due to suspected disciplinary violations. As of the date of this announcement, the company was unaware of the progress and conclusion of the investigation. The company's other directors, senior management personnel and supervisors all perform their duties normally. The board of directors performs relevant duties in accordance with the law, and the production and operation management situation is normal.
Improve Medical Instruments Co., Ltd.'s (SZSE:300030) Shares Bounce 31% But Its Business Still Trails The Industry
Improve Medical Instruments Co., Ltd. (SZSE:300030) shareholders are no doubt pleased to see that the share price has bounced 31% in the last month, although it is still struggling to make up recently
Yangpu Healthcare (300030.SZ): As of February 8, 2024, the total number of shareholders of the company was about 26,600
Gelonghui, Feb. 19 | Yangpu Medical (300030.SZ) said on an interactive platform that as of February 8, 2024, the total number of shareholders of the company was about 26,600.
Investors Don't See Light At End Of Improve Medical Instruments Co., Ltd.'s (SZSE:300030) Tunnel And Push Stock Down 27%
Improve Medical Instruments Co., Ltd. (SZSE:300030) shareholders that were waiting for something to happen have been dealt a blow with a 27% share price drop in the last month. The drop over the la
Yangpu Medical (300030.SZ) issued an advance loss, with an estimated net loss of 45 million yuan to 65 million yuan in 2023
Yangpu Healthcare (300030.SZ) disclosed its 2023 annual results forecast. The company is expected to belong to listed company shares...
Yangpu Healthcare (300030.SZ): As of December 20, 2023, the total number of shareholders of the company was about 27,400
Gelonghui December 25 | Yangpu Medical (300030.SZ) said on an interactive platform that according to data provided by China Securities Registration and Settlement Co., Ltd., as of December 20, 2023, the total number of shareholders of the company was about 27,400.
Yangpu Medical (300030.SZ): There are currently no relevant testing products
On November 27, Gelonghui, some investors asked Yangpu Healthcare (300030.SZ) on the investor interactive platform, “Now that mycoplasma infection and the virus are superimposed on it, the company has any testing products used to improve prevention and service to the community.” The company replied that the company currently has no relevant testing products.
Yangpu Medical (300030.SZ) released the first three quarter results, net profit increased by 105.51%
Yangpu Medical (300030.SZ) released its report for the third quarter of 2023, and achieved revenue of 4.7 in the first three quarters...
Yangpu Medical (300030.SZ): The company is currently the only domestic vacuum blood collection company registered by the US FDA
Gelonghui September 18 | Yangpu Medical (300030.SZ) said at an investor relations event on September 18 that the company is a leading enterprise in the domestic vacuum blood collection system industry, and is currently the only domestic vacuum blood collection company registered with the US FDA. After nearly 30 years of development, the company has a team of professional blood testing experts, has accumulated a deep academic heritage in the field of blood, and has a good academic reputation, including participating in the formulation and revision of national standards and industry standards for products such as vacuum blood collection tubes and thromboelastography. It is one of the main drafters of the standards.
Yangpu Medical (300030.SZ) withdrew its application and increased the application documents through simplified procedures
Yangpu Medical (300030.SZ) announced that the fourth session of the sixth board of directors of the company was held on September 4, 2023...
Yangpu Medical (300030.SZ) released the first half of the year results, turning a loss into a profit of 10.464,400 yuan
Yangpu Medical (300030.SZ) released the 2023 semi-annual report. During the reporting period, the company achieved operating income...
Improve Medical Instruments (SZSE:300030 Investor Three-year Losses Grow to 48% as the Stock Sheds CN¥365m This Past Week
Many investors define successful investing as beating the market average over the long term. But if you try your hand at stock picking, your risk returning less than the market. We regret to report
Yangpu Healthcare (300030.SZ): Real estate rights and ancillary facilities under the name of Yangpu in Chenzhou to be withdrawn, the transaction amount is about 597.729 million yuan
Yangpu Medical (300030.SZ) announced that on August 16, 2023, the company's wholly-owned subsidiary Chenzhou Yangpu...
Yangpu Medical (300030.SZ): The company is developing an AI-based fully automated thromboelastography system project and a molecular diagnostic blood collection vessel construction project
GLONGHUI July 24丨Some investors asked Xiang Yangpu Healthcare (300030.SZ): How is the company's R&D investment? What are the R&D results? Yangpu Medical replied: The company attaches importance to R&D and continues to promote technological innovation. In 2022, the company's R&D investment accounted for 6.14% of revenue, up 0.61 percentage points from the same period last year. At the same time, the company is based on independent R&D and innovation, and most of the R&D team are professionals in the fields of biochemistry and clinical medicine. In 2022, the company and subsidiaries obtained 24 new patent authorizations, including 3 invention patents and 20 utility models in China
Yangpu Healthcare (300030.SZ): Many of the company's products have EU CE certification, US FDA certification, and market entry qualifications from Canada, Brazil and other countries
Glonway July 24丨Some investors asked Xiang Yangpu Healthcare (300030.SZ): What are the certifications in Europe and the US? What is the layout of overseas markets? Yangpu Medical's response: Many of the company's products have EU CE certification, US FDA certification, and market entry qualifications from Canada, Brazil and other countries. The company's quality system can also meet the requirements of ISO9001, ISO13485, QSR820, MDD, MDR, IVDR and MDSAP quality management systems. The market covers more than 100 countries and regions around the world, providing products and technology for nearly 10,000 well-known medical institutions
Yangpu Medical (300030.SZ): The company's thromboelastograph uses magnetic moment sensing notation
GLONGHUI July 24丨Some investors asked Yangpu Healthcare (300030.SZ): What is the testing principle of a thrombus elasticity meter? Yangpu Medical's response: The company's thromboelastograph uses a magnetic moment sensing notation method to drive the cup lid to rotate at a fixed angle. The rotation speed of the cup cover changes with blood sample coagulation, that is, simulates the mechanical reaction of human blood coagulation in vitro and measures the speed of blood clotting and thrombus resolution, thus drawing and forming a thrombus elasticity graph curve.
Yangpu Medical (300030.SZ): The company sells vacuum blood collection vessels mainly in hospitals, complemented by third-party medical examination institutions
GLONGHUI July 24丨Some investors asked Xiang Yangpu Healthcare (300030.SZ): What is the company's main sales channel for vacuum blood collection vessels? Yangpu Medical replied: In terms of sales channels, the company's vacuum blood collection channels account for domestic direct sales channels for about 25%, and distribution channels account for about 75%; overseas sales are all distribution. In addition, the company sells vacuum blood collection vessels mainly in hospitals, complemented by third-party medical examination institutions.
Analysis
Price Target
No Data
